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Abstract 
Ozone major autohemotherapy (O-MAHT) is a way of ozonetherapy
administration consisting of drawing patient’s venous blood, mixing
with oxygen/ozone, and reinfusing it into the vein. Some ozone thera-
pists reported side effects during the O-MAHT, but the origin has not
been described yet. We investigated the effect of blood drawing velocity
during O-MAHT to see its effects on the vascular system and sympto-
matology. We administered O-MAHT to 11 subjects, and we interleaved
fast and slow reinfusions. We monitored cerebral macrocirculation
with transcranial Doppler (TCD) and tissue microcirculation with
near-infrared spectroscopy (NIRS). Annoying symptoms appeared just
during the fast reinfusion periods. NIRS and TCD parameters revealed
vasoconstriction during fast reinfusion and improved metabolism dur-
ing slow reinfusion. Overall, our investigation well discriminated fast
from slow reinfusion velocity.
Introduction
The main benefits of ozone therapy on humans are: the antibiotic
effect and static effect on viruses,1-4 activation of the mitochondrial
antioxidant system,5-7 increased adenosine triphosphate (ATP) pro-
duction, hemorheological effect with greater activity of the oxygen-car-
bon dioxide exchange in red blood cells,8 and anti-inflammatory
action.9 In addition, there is reactivation of the cerebral microcircula-
tion and metabolism,7 an anti-ischemic protective effect,10-12
antithrombotic effect,13 and anti-tumor action.
For several decades these properties have prompted its use in ortho-
pedic diseases such as osteoarthritis, arthritis, and herniated discs,14-16
contributing significantly to the reduction in surgical treatment and
improving patients’ quality of life; moreover, arterial and venous vas-
cular diseases, and metabolic, autoimmune, infectious and neoplastic
diseases also benefit from it.17,18 Ozone induces the repair of tissue
damage through the release of several growth factors and by activating
the body’s own stem cells.19,20
The occurrence of side effects during ozone therapy is still contro-
versial: while some studies report the total absence of adverse
effects,6,21 other authors have reported side effects, especially for local,
intradiscal and paravertebral injections:22,23 there have been reports of
burning sensations with subcutaneous injections at high concentra-
tions and pain due to distension of the muscle fascia with paraverte-
bral injections for herniated discs. This sensation can be reduced by
injecting more slowly, at lower ozone concentrations and with reduced
volumes of gaseous mixture. However, the studies published have not
reported that ozone is directly responsible.
Another mode of administration for ozone therapy is ozone major
autohemotherapy (O-MAHT). This consists in drawing venous blood
from the patient, usually from 100 to 240 g, and after the blood is mixed
with an oxygen/ozone (O2-O3) mixture, it is reinfused through the same
vein. In the guidelines on the practice of O-MAHT, it is often suggested
that low ozone concentrations and stoichiometric amounts be used with
respect to the blood to be treated for an overall reduction in side
effects.24,25 However, some ozone therapy practitioners have observed the
sporadic appearance of perioral paresthesia, feelings of warmth and/or
tachycardia, sensations of coolness in the chest area, and fainting during
O-MAHT. These side effects may arise from reinfusing the blood-O2-O3
mixture too quickly. In fact, as has already been pointed out in an earlier
study7 fast reinfusion may cause an increase in peripheral resistance,
probably due to the effect of the volume that induces a response from the
autonomic nervous system underlying the reported side effects.
Given the fact that no studies have been found in the literature that
make clear reference to adverse effects resulting from the different
speeds of reinfusion of the blood-O2-O3 mixture during O-MAHT, the aim
of this article is to verify whether the speed of reinfusion during O-
MAHT could be correlated with such events. We therefore concomitantly
monitored both the blood flow through the middle cerebral artery
(MCA), using the transcranial Doppler method (TCD), and the microcir-
culation, using near-infrared spectroscopy (NIRS). The first method per-
mits the measurement of the speed of the blood flow and the peripheral
resistance.26 NIRS permits the evaluation of tissue oxygenation, which
is closely related to a greater or lesser opening of the microcirculation.27
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Both are suitable for continuous monitoring of cerebral hemodynamics
as they are relatively inexpensive and non-invasive methods.
Materials and Methods
The study involved an analysis of the effect of the speed of reinfusion
during O-MAHT. For this reason, changes in the micro- and macro-circu-
lation were measured in a group of 11 subjects using NIRS and TCD sig-
nals respectively. These signals were divided into observation windows of
interest. Within each window, quantitative parameters were measured
in the time domain, frequency domain and indices of interest.Subjects
A sample of 6 control subjects with no previous history of brain dis-
orders was analyzed. Five subjects with a history of inflammatory neu-
rological or neurodegenerative disease were also analyzed: in particu-
lar, the sample included two patients with relapsing-remitting multiple
sclerosis (MS), two subjects suffering from disorders of movement -
Parkinsonism, and one with arterial hypertension. In total, 11 subjects
were analyzed. A heterogeneous sample was selected to evaluate
whether or not the adverse effects reported by some authors during O-
MAHT were due to a specific pathology. All subjects signed informed
consent after being informed about the procedures, timing, purpose
and potential side effects of the examination.Autohemotherapy
Each subject was placed on an examination couch in the supine
position in a quiet, comfortable room. In addition, subjects was asked
to keep their eyes closed and breath normally. Of venous blood, 180 g
was drawn from a vein in the subject’s arm. A mixture of 180 mL O2-O3
with an O3 concentration of 40 µg/mL was added to the blood, and lastly,
after suitable slow mixing, the blood-O2-O3 mixture was reinfused by
gravity into the same vein as was used to draw the patient’s blood. A
Medical 95 CPS ozone-dispensing machine from Multiossigen Srl
[Gorle (BG), Italy] and a SANO3 kit for autohemotherapy from
Haemopharm Healthcare Srl [Sondalo (SO), Italy] were used. The
blood was reinfused at two different speeds: fast reinfusion and slow
reinfusion. The speed of reinfusion was varied by changing the height
of the bag containing the blood-O2-O3 mixture: for fast reinfusion, the
height was set at about 60 cm from the patient’s heart level, while for
slow reinfusion the height was lowered to about 20-30 cm from the
heart level. The speed of the mixture flowing out from the bag was over
80 drops/min during fast reinfusion, while during slow reinfusion it
was less than 50 drops/min. It was not necessary to continuously meas-
ure the speed of reinfusion: in fact, the point of interest was not the
exact speed but to highlight any different sensations felt by the same
patient in relation to the different speeds of reinfusion. This differ-
ence, due to the gravitational effect, was ensured by the difference in
the height of the position of the bag. In addition, fast reinfusion was
alternated with slow reinfusion in order to reduce the amount of time
in which the subjects felt any discomfort. The change in speed occurred
after having reinfused approximately 50 g of the mixture.
In summary, the following windows of observation were defined:
baseline; blood collection; first fast reinfusion of the mixture (FAST1);
slow reinfusion of the mixture (SLOW); second fast reinfusion of the
mixture (FAST2).Test measurements
The NIRS recordings were made by constantly using a two-channel
commercial device (NIRO200NX, Hamamatsu Photonics, Japan)
throughout the examination time. The NIRS probes (nominal peak
wavelength of 735, 810, and 850 nm) were positioned at the level of the
frontal lobe of the dominant hemisphere and the right tibialis anterior
muscle. The brain probe was placed on the subject’s forehead 2 cm from
the midline and 1 cm above the supraorbital ridge. Information was thus
obtained on the microcirculation in the cerebral and peripheral tissue.
The relative concentrations of oxygenated (O2Hb) and deoxygenated
(HHb) hemoglobin were recorded. The total hemoglobin value (totHb)
was also determined as the sum of O2Hb and HHb. The signals were
sampled at a frequency of 2 Hz and analyzed in the time domain and fre-
quency domain. In the time domain, the relative average concentration
values of O2Hb and HHb were measured in each window of observation.
In the frequency domain, the signals were analyzed using time-frequen-
cy analysis since the NIRS signal is not stationary. A Cohen’s class Choi-
Williams (CW) distribution was used with a Gaussian kernel with
σ=0.5.28 The relative power of the O2Hb and HHb signals was measured
from the CW in three bands of interest: very-low frequency (VLF) in the
20-60 MHz band, low frequency (LF, 60-140 MHz) and high frequency
(HF, 140-250 mHz). The VLF band is linked to long-term motor vasore-
activity. The LF band is related to the activity of the sympathetic and
parasympathetic system, and therefore to cerebral autoregulation. It is
generally a stronger indicator of sympathetic system activity.29,30 The HF
band is linked to the activity of the vagal nerve. Finally, the LF/HF ratio
is indicative of the sympatho-vagal balance and reflects sympathetic
modulation.31,32 Finally, the total power (PTOT) was measured for cere-
bral (O2Hbc, HHbc) and muscle (O2Hbm, HHbm) NIRS parameters. The
percentage of relative power for the VLF, LF and HF bands was calculated
as PVLF/PTOT, PLF/PTOT, and PHF/PTOT. These parameters were calculated for
O2Hb and HHb in all the windows of observation.
The TCD signal was acquired at the same time as the NIRS signal. A
commercial device (Delica EMS-9UA; Shenzhen Delicate Electronics
Co., Tian-an, China) with a 2 MHz probe was used. The probe was posi-
tioned to achieve a flow signal from the right middle cerebral artery
over the temporal window at the level of the M1 segment. Within each
window, the mean values of the following TCD parameters were meas-
ured: peak systolic speed (SS); diastolic downstream speed (DD);
gosling pulsatility index (PI); index of resistance (IR); heart rate (HR).
Overall, for each subject, 23 parameters were measured in each win-
dow of observation: 5 TCD parameters, 9 NIRS cerebral parameters and
9 NIRS muscle parameters.
Finally, the systemic oxygen saturation and arterial blood pressure
(ABP) were monitored throughout the examination at the beginning of
each temporal window. The ABP values were used for the calculation of
the mean arterial pressure (MAP).Statistical analysis
The duration of the reinfusion windows were compared using one-
way analysis of variance (ANOVA). The MAP values during the baseline
interval and during the reinfusions were compared using one-way
ANOVA analysis. Subsequently, the FAST1 and FAST2 windows were
averaged thus obtaining a single FAST observation window.
Multivariate analysis of variance (MANOVA) was performed with all 23
TCD and NIRS parameters.
Results
In Table 1 the demographic data of the study sample is shown. It may
be noted that the average duration of the FAST1, SLOW, and FAST2
reinfusions did not differ between the control subjects and those affect-
ed by disease (one-way ANOVA, P>0.1). The MAP values in the differ-
ent observation windows were compared using one-way ANOVA and did
not undergo any significant changes during the examination.
All subjects reported at least one of the following side effects during
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fast reinfusions: tingling in the mouth and legs, a metallic taste in the
mouth, pulsing temples, a sensation of warmth in the cheeks, a feeling
of cold and tightness in the chest. These symptoms occurred during
fast reinfusion and immediately disappeared after a reduction in the
speed of reinfusion; they reappeared if the speed of reinfusion was
increased again.
The percentage change in the concentration of O2Hb, HHb and totHb
was calculated. The average concentration of the baseline window was
taken as a reference. The relative changes are reported in Figure 1 both
at the cerebral level (A) and the muscular level (B). In Table 2 the average
values of the peak systolic speed SS and DD diastolic downstream speed
are reported, as are the indices PI, IR and HR in the 5 windows of obser-
vation. It is stressed that the SS increases slightly during fast reinfusion,
as do the parameters PI and IR, when compared to slow infusion. In gen-
eral, one can observe a different organ reaction to the O2-O3 mixture. In
the brain, it can be observed that the concentration of totHb decreases
starting from the withdrawal window. Compared with baseline, the blood
collection manoeuvers cause a decrease in O2Hb, as in a state of alarm or
reactions to pain. During FAST1 reinfusion, and especially during FAST2
reinfusion, we see a reduction in the O2Hb concentration together with
constant HHb. The TCD findings document an increase in the indices of
peripheral vascular resistance PI and IR in the territory of the MCA. These
conditions point to peripheral vasoconstriction and reduction of the tissue
bed of the microcirculation. During slow reinfusion, an increase in the
vascular bed of the microcirculation is observed, which is line with the
slight increase in the DD and reduction in the IR. At the muscular level,
during fast reinfusion vasoconstriction can be observed which manifests
as an increase in the concentration of HHb and a decrease in O2Hb. In the
subsequent windows, there is a tendency to increase O2Hb and decrease
HHb. Slow reinfusion favors the use of oxygen with greater representa-
tion, particularly in the muscle, of HHb and constant totHb. The changes
in the microcirculation appear on the instrumentation a few seconds
before the subject points out the symptoms listed above.
The LF/HF ratio was subsequently calculated in the reinfusion win-
dows, this being indicative of sympathetic and parasympathetic regula-
tion. The average values for all the subjects are shown in Figure 2. It
can be observed that the ratio of the powers is lower during slow rein-
fusion than fast reinfusion.
Lastly, in order to evaluate the different behavior of the modes of
reinfusion the curves of the FAST1 and FAST2 windows were averaged
into one FAST window for which the average value was calculated.
MANOVA was performed to take into account all the parameters of
the macro- and micro-circulation. MANOVA analysis of the FAST and
SLOW modes confirms the different effect in the circulation (Wilks’
lambda=0.006). A canonical variable allows the fast reinfusion method
to be distinguished from the slow mode (Figure 3). 
Discussion
This study was aimed at evaluating the correlation between the
occurrence of side effects observed clinically during O-MAHT and the
speed of the reinfusion of the blood O2-O3 mixture. For this purpose, a
group of subjects received O-MAHT with different reinfusion speed
windows. The results obtained showed a modulation in frequency,
which is reflected in the subjective symptoms reported.
The positive effects of O-MAHT have already been documented in
one of our earlier studies:7 monitoring the tissue microcirculation
using NIRS, an increase was observed in brain oxygenation after about
1.5 hours’ infusion of ozonated blood. In addition, people with MS have
shown an increase in the activity and concentration of cytochrome c
oxidase for up to 40 minutes after the end of treatment. These results
have shown that a blood-O2-O3 mixture causes variations in the micro-
circulation and metabolic changes which are stable over time. These
are obtained thanks to the steady-state homogeneous diffusion of the
mixture, favored by an infusion rate that helps to achieve this.
However, there was no documentation on the effects of the mode of
reinfusion on subjective symptoms. Many of the effects described as
adverse in the literature are essentially present during the phase of
fast reinfusion and actually seem to be due to iatrogenic action related
to incorrect management of the reinfusion times, in particular the
speed of reinfusion, rather than related to the toxicity of the molecule. 
Regarding the time needed for reinfusion, some variations have been
observed compared to the baseline condition, which, besides being pres-
ent in the microcirculation, also reflect on the macrocirculation. 
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Table 1. Demographic data (mean±standard deviation) of the study sample and duration of the observation windows.
Group                     N               Age (years)             BMI                                                                Duration (s)
                                                                                                       Baseline         Withdrawal           FAST1                SLOW                FAST2
Healthy                          6                        58.7±17.3                  25.3±3.3                223.2±34.4                135.7±83                186.1±41.7             343.8±139.2             124.7±49.8
Pathology                       5                        53.5±15.8                  22.7±2.1                271.9±33.2              120.4±59.1               152.6±88.8             286.1±171.6             145.6±70.4
Total                              11                       56.8±16.1                  24.3±3.1                240.9±40.5              130.1±72.4                174±60.8                322.8±146               132.3±55.6
BMI, body mass index; FAST1, fast reinfusion period 1; SLOW, slow reinfusion period; FAST2, fast reinfusion period 2.
Table 2. Transcranial Doppler parameters (mean±standard deviation) in the five windows of observation. 
                                    SS (cm/s)                      DD (cm/s)                             PI                                    IR                                   HR
Baseline                              64.222±12.99                            26.795±4.75                              0.876±0.19                              0.570±0.085                             50.365±8.30
Withdrawal                          63.985±17.18                            28.315±5.79                              0.819±0.15                              0.549±0.062                             55.634±8.08
FAST1                                   66.016±15.52                            29.099±6.36                              0.827±0.16                               0.552±0.07                              52.257±7.06
SLOW                                   65.010±16.94                            29.187±8.42                              0.819±0.16                               0.550±0.06                              54.389±9.04
FAST2                                   66.854±16.60                            28.631±6.84                              0.854±0.16                               0.566±0.07                              53.851±6.36
SS, systolic speed; DD, diastolic downstream speed; PI, pulsatility index; IR, index of resistance; HR, heart rate; FAST1, fast reinfusion period 1; SLOW, slow reinfusion period; FAST2, fast reinfusion period 2. An increase
in systolic speed, downstream speed and heart rate and a decrease in pulsatility index and index of resistance can be observed during the reinfusion with respect to the baseline window.
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Autoregulation in the brain by variations in volume in the microcir-
culation, in particular of the venous outflow, is regulated mainly by the
autonomic nervous system and is closely related to the compliance of
the intracranial pressure (ICP). The changes in these parameters dur-
ing the period of drug treatment (FAST1 to FAST2 windows) could be
the cause of the subjective symptoms: indeed, the variations in volume
caused by reinfusion affect the autonomic nervous system, as demon-
strated by changes in the LF/HF ratio. Given the constant MPA, this
effect can only be related to the CPP (Cerebral Partial Pressure)
changes. This hypothesis is supported by the changes in speed in the
SS and in the IP and IR indices. The changes in volume reflect on the
ICP and, therefore, on the resistances and the compliance of the flow,
as a result of an autoregulation mechanism of the autonomic nervous
system. Overall, the spectrographic NIRS findings and TCD flow rates
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Figure 1. The mean value and standard error of the average concentration of oxygenated, deoxygenated, and total hemoglobin (O2Hb,
HHb, and totHb, respectively) with respect to the baseline window in the baseline, sampling, fast reinfusion (FAST1 and FAST2) and
slow reinfusion (SLOW) windows. In the brain (A), there was an average decrease in O2Hb, accompanied by an almost constant con-
centration of HHb. In the muscle (B), a progressive increase in the HHb concentration and a decrease in O2Hb concentration were
observed and were greater in the slow reinfusion window.
Figure 2. Average percentage value of the low/high frequency
(LF/HF) ratio in the fast (FAST1 and FAST2) and slow (SLOW)
brain windows. The ratio is lower in the slow reinfusion window
than in the fast reinfusion windows.
Figure 3. Result of the MANOVA for the two modes of reinfusion
FAST (circles) and SLOW (squares). The two modes are well sep-
arated in the plane of the two canonical variables.
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indicate changes in muscle tone, in the precapillary sphincters and in
the tone in sympathetic venular outflow that influence CPP and thus
ICP. This activity of the autonomic nervous system allows, in the analy-
sis of the overall system, two areas to be identified which are defined
according to the mode of reinfusion. In the muscle, as in the brain, we
have the spectral modifications that confirm the variations in circula-
tion in relation to changes in the sympathetic-parasympathetic tone.
To summarize, we have: i) from a clinical point of view, modulating
autonomic-sympathetic symptoms; ii) in terms of clinical tests, the
TCD-NIRS measurements which indicate an autoregulatory response
to an increase in systemic O2; and iii) the pharmacological action of
ozone, thus a stimulus with a strong redox action, because besides
changes in the circulation, variations in the cellular energy metabolism
probably take place as well.
Conclusions
The study presented was designed to investigate the effect of the
speed of reinfusion during O-MAHT. A group of subjects received two
speeds of reinfusion and the micro- and macro-circulations at the
peripheral and cerebral levels were measured. The instrumental analysis
showed different behaviors in the two conditions due to different actions
from the autoregulation mechanisms and variation in the peripheral
resistance. Future studies will involve the enrolment of a larger number
of subjects and the comparison of symptoms and vascular parameters
during reinfusion in alternative conditions to ozone. In addition, a work-
ing hypothesis emerging from the analysis of the data collected could be
that, from a functional point of view, there is a better activity of the ener-
gy metabolism in the brain tissues in clinically healthy patients.
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